Ranjit Shahani, the former chief of Novartis India Ltd. and the face of the Swiss multinational in the country for over a decade, including during the tumultuous Glivec (imatinib mesylate) patent battle years, has died aged 74.
Obituary: Ranjit Shahani, Ex-Novartis India Chief Who ‘Traveled Light’
Industry veteran and mentor to many, Ranjit Shahani steered Novartis India with seeming calm through a rocky phase when the Glivec patent case ruling didn't go the Swiss multinational's way - perhaps not unusual for someone who had seen the ebbs and flows of life closely when his parents moved to India as refugees from Pakistan.
